Skip to main content
Figure 2 | Italian Journal of Pediatrics

Figure 2

From: Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience

Figure 2

Clinical and pharmaco-economic data in control (Group A) and actively-treated (Group B) patients. A = number of days with fever; B = number of days with medication use; C = number ofmedical visits; D = number of days with school absence in Group A (control) and Group B (resveratrol plus carboxymethyl-β-glucan) assessed 30 days (T1), 60 days (T2), and 90 days (T3) after anti-infective and anti-inflammatory treatment.

Back to article page

Italian Journal of Pediatrics

ISSN: 1824-7288

Contact us